In vitro studies demonstrate IL-8 involvement in cell growth and migration, particularly in NSCLC cell lines with K-ras mutations, and siRNAs against K-ras downregulate IL-8 [39]. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.